Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44,542,200
-
Total 13F shares
-
13,534,368
-
Share change
-
+2,989,399
-
Total reported value
-
$95,028,004
-
Price per share
-
$7.01
-
Number of holders
-
31
-
Value change
-
+$21,079,273
-
Number of buys
-
18
-
Number of sells
-
6
Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q2 2022
As of 30 Jun 2022,
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,534,368 shares.
The largest 10 holders included
Essex Woodlands Management, Inc., ORBIMED ADVISORS LLC, Opaleye Management Inc., RTW INVESTMENTS, LP, Industry Ventures, L.L.C., PURA VIDA INVESTMENTS, LLC, Velan Capital Investment Management LP, VANGUARD GROUP INC, Pentwater Capital Management LP, and AIGH Capital Management LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.